Michael Dukes

3.7k citations
16 papers · 2.6k · 2 hit papers · h-index 11

Impact in

  • Genetics top 2%
    • Estrogen and related hormone effects
  • Oncology top 5%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology

Papers in

    • Estrogen and related hormone effects 9
    • Angiogenesis and VEGF in Cancer 3
    • Steroid Chemistry and Biochemistry 2

Michael Dukes

16 papers receiving 2.5k citations

Michael Dukes's Hit Papers

ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration. 2002 · 720 citations
7200+11+23Years since publication250500750

Peers

Michael Dukes
Comparison fields: 5 of 100
  • Genetics 974
  • Oncology 778
  • Cancer Research 398
  • Endocrinology, Diabetes and Metabolism 344
  • Reproductive Medicine 174
Replace Alan E. Wakeling with:
Alan E. Wakeling United Kingdom
Yolande Berthois France
Yoko Omoto Japan
Anne E. Lykkesfeldt Denmark
Dany Chalbos France
Helmut Dotzlaw Canada
Sophie Dauvois Canada
Ciro Abbondanza Italy
Elizabeth Anderson United Kingdom
Suzanne E. Wardell United States
Michael Dukes relative to Alan E. Wakeling United Kingdom Alan E. Wakeling's profile →
Citations per field
00.5×1.5×
Alan E. Wakeling · 1×
Citations per year

Countries citing papers authored by Michael Dukes

Since Specialization
Citations

This map shows the geographic impact of Michael Dukes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Dukes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Dukes more than expected).

Fields of papers citing papers by Michael Dukes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Dukes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Dukes. The network helps show where Michael Dukes may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Dukes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Dukes Line = papers co-authored together Michael Dukes links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1
A potent specific pure antiestrogen with clinical potential.
Hit paper breakdown →
1991990
2
ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration.
Hit paper breakdown →
2002720
3 2002263
4 1994222
5
ZD4190: an orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacy.
2000172
6 199675
7 199459
8 199254
9 200349
10 200015
11
A case of adenomyosis in a pigtailed monkey diagnosed by magnetic resonance imaging and treated with the novel pure antiestrogen, ICI 182,780.
199310
12 19927
13 20096
14 19914
15 20111
16 20041

About Michael Dukes

Michael Dukes is a scholar working on Genetics, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism and Reproductive Medicine, having authored 16 papers that have together received 2.6k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (9 papers), Endometriosis Research and Treatment (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Advanced MRI Techniques and Applications (3 papers), Menopause: Health Impacts and Treatments (3 papers), Steroid Chemistry and Biochemistry (2 papers), Reproductive System and Pregnancy (2 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). The work is most often cited by research in Genetics (974 citations), Oncology (778 citations), Cancer Research (398 citations), Endocrinology, Diabetes and Metabolism (344 citations) and Reproductive Medicine (174 citations). Michael Dukes has collaborated with scholars based in United Kingdom, United States and Singapore. Frequent co-authors include A. E. Wakeling, Jean Bowler, Stephen R. Wedge, Jane Kendrew, Jon Curwen, Laurent Hennequin, Elaine S. E. Stokes, Martin C. Dyroff, Paul V. Plourde and Donald Ogilvie. Their work appears in journals such as Journal of Endocrinology, Journal of Medicinal Chemistry, Laboratory Animals, Breast Cancer Research and Treatment and Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact